Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brenton

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Oncogene|August 29, 2006
A gene-expression signature to predict survival in breast cancer across independent data setsA Naderi, A E Teschendorff, N L Barbosa-Morais, et al.
Magnetic Resonance in Medicine|April 8, 2010
Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic diseaseAndrew N Priest, Andrew B Gill, Masako Kataoka, et al.
Genome Biology|January 23, 2015
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifierFilipe C Martins, Ines de Santiago, Anne Trinh, et al.
Plos One|December 4, 2009
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumorsKasmintan A Schrader, Bella Gorbatcheva, Janine Senz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samplesA M Piskorz, D Ennis, G Macintyre, et al.
Nature|June 15, 2022
A pan-cancer compendium of chromosomal instabilityRuben M Drews, Barbara Hernando, Maxime Tarabichi, et al.
European Radiology|August 7, 2009
Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical developmentEvis Sala, Andrew N Priest, Masako Kataoka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerI Vergote, A González-Martín, I Ray-Coquard, et al.
Oncogene|May 18, 2005
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenesMaria J Garcia, Jessica C M Pole, Suet-Feung Chin, et al.
Elife|May 11, 2023
High-grade serous ovarian carcinoma organoids as models of chromosomal instabilityMaria Vias, Lena Morrill Gavarró, Carolin M Sauer, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Oncogene|August 29, 2006
A gene-expression signature to predict survival in breast cancer across independent data setsA Naderi, A E Teschendorff, N L Barbosa-Morais, et al.
Magnetic Resonance in Medicine|April 8, 2010
Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic diseaseAndrew N Priest, Andrew B Gill, Masako Kataoka, et al.
Genome Biology|January 23, 2015
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifierFilipe C Martins, Ines de Santiago, Anne Trinh, et al.
Plos One|December 4, 2009
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumorsKasmintan A Schrader, Bella Gorbatcheva, Janine Senz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samplesA M Piskorz, D Ennis, G Macintyre, et al.
Nature|June 15, 2022
A pan-cancer compendium of chromosomal instabilityRuben M Drews, Barbara Hernando, Maxime Tarabichi, et al.
European Radiology|August 7, 2009
Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical developmentEvis Sala, Andrew N Priest, Masako Kataoka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerI Vergote, A González-Martín, I Ray-Coquard, et al.
Oncogene|May 18, 2005
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenesMaria J Garcia, Jessica C M Pole, Suet-Feung Chin, et al.
Elife|May 11, 2023
High-grade serous ovarian carcinoma organoids as models of chromosomal instabilityMaria Vias, Lena Morrill Gavarró, Carolin M Sauer, et al.
Pageof 23